Charles River Laboratories International (CRL) Price to Earnings (2009 - 2026)

Charles River Laboratories International has reported Price to Earnings for 18 years, with the latest figure at 13549.1 in Q2 2026.

• On a quarterly basis, Price to Earnings fell 9704.25% year-over-year to 13549.1 in Q2 2026; TTM through Jun 2026 was 43.32, a 59.37% increase from a year earlier, with the FY2025 full-year figure at 69.44, down 107.51% from the prior year.
• Price to Earnings was 13549.1 for Q2 2026 at Charles River Laboratories International, down from 517.92 in the prior quarter.
• The five-year high for Price to Earnings was 299.97 in Q1 2025, with the low at 13549.1 in Q2 2026.
• Average Price to Earnings over 5 years is 683.23, with a median of 107.56 recorded in 2022.
• The sharpest annual moves came in 2024 and 2026: Price to Earnings surged 106.96% in 2024, then slumped 9704.25% in 2026.
• Over 5 years, Price to Earnings stood at 58.7 in 2022, then increased by 10.51% to 64.87 in 2023, then sank by 168.04% to 44.14 in 2024, then advanced by 17.88% to 36.24 in 2025, then sank by 37282.74% to 13549.1 in 2026.
• The last three Price to Earnings figures came in at 13549.1 (Q2 2026), 517.92 (Q1 2026), and 36.24 (Q4 2025), per Business Quant data.